𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Electron-microscopic study of the mouse myocardium in experimental Coxsackie A13 virus infection

✍ Scribed by V. P. Kaznacheev; E. F. Bocharov; V. A. Shkurupii; O. B. Meleshina


Publisher
Springer US
Year
1977
Tongue
English
Weight
829 KB
Volume
83
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Coxsackie virus B4 infection of the mous
✍ C. Vella; A. J. Easton; R. P. Eglin; C. L. Brown; L. Perry πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 464 KB

## Abstract The pathology of Coxsackie virus B4 (CVB4) infection in a murine model was investigated by in situ hybridization using a biotinylated cDNA probe derived from CVB4. During the acute phase of infection virus RNA sequences were detected in the exocrine pancreas of 60% of mice infected with

Three-dimensional structure of the Golgi
✍ Ho, Han-Chen ;Tang, Chih-Yuan ;Suarez, Susan S. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 573 KB

In this study, the three-dimensional organization of the Golgi apparatus in mouse spermatids was elucidated by preparing testicular tissue with the osmium-DMSO-osmium method and examining it by stereo-scanning electron microscopy. The cis-most saccule was found to be a regular network of anastomotic

Neutralization of Hepatitis B Virus Infe
✍ Dr. Sten Iwarson; Edward Tabor; Howard C. Thomas; Allison Goodall; Jenny Waters; πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 440 KB πŸ‘ 2 views

## Abstract Two study chimpanzees were inoculated intravenously with approximately 1,000 chimpanzee infectious doses of hepatitis B virus (HBV), one with subtype adr and one with subtype ayw, each previously incubated with 0.1 ml of a murine monoclonal antibody (IgG ~1(K)~ class) directed against a

Experimental approach to the study of im
✍ S. Cunningham-Rundles; R. Yeger-Arbitman; P. Edelson; D. Sanders; P. V. Giardina πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 647 KB

## Abstract The clinical immunology laboratory is often called on to assess risk in pediatric patients with clinical evidence of immunodeficiency and possible human immunodeficiency virus (HIV) exposure while antibody tests are being considered or are underway. Since non–HIV‐related conditions incl